Accreditation/Credit Designation

Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Sanofi Genzyme.

Community Practice Connections™: Recognizing and Treating Oncologic Emergencies in the Cancer Patient: What Does the Nurse Need to Know?

Release Date: June 30, 2019
Expiration Date: June 30, 2020
Media: Internet - based

Activity Overview

Response to oncologic emergencies is a critical component of patient care, and continued research has the potential to improve responses and outcomes. This online program features oncology nursing specialists who will highlight best practices in identifying patients at risk for oncologic emergences, strategies to recognize and treat associated symptoms, and applications of nursing management strategies across a continuum of care. In addition, our faculty will review recent clinical trial data for the prevention and management of oncolytic emergencies. Topics include tumor lysis syndrome, febrile neutropenia, venous thromboembolism, hyperkalemia, and other oncologic emergencies. Expert video interviews interspersed with the latest research will assist in the integration of cutting-edge data and guideline-based care into the plan of care for your patients.

Benefits of Participating

  • Hear expert perspectives on up-to-date strategies for monitoring and managing oncologic emergencies
  • Review the spectrum of oncologic emergencies your patients may face to improve early recognition and treatment
  • Learn about recent clinical trial data with the potential to change treatment paradigms in the management of oncologic emergences

CME Activity Table of Contents

  • Pretest
  • Oncologic Emergencies Part I: Management of Tumor Lysis Syndrome and Electrolyte Abnormalities
  • Oncologic Emergencies Part II: Management of Febrile Neutropenia and Other Oncologic Emergencies
  • Oncologic Emergencies Part III: Management of Venous Thromboembolic Risk and Adrenal Insufficiency
  • Posttest

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Sanofi Genzyme.

Instructions for This Activity and Receiving Credit

  • You will need to log in to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review audio files/content until you finish the presentation.
  • At the end of the activity, educational content/audio files will be available for your reference.
  • In order to receive a CME/CE certificate, you must complete the activity.
  • Complete the Posttest and pass with a score of 70% or higher, complete the Evaluation, and then click on “Request for Credit.” You may immediately download a CME/CE certificate upon completion of these steps.

Target Audience

This educational program is directed toward physicians, nurses, and other healthcare professionals who treat patients with cancer.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Describe the pathophysiologic characteristics of oncologic emergencies, including serious infections, tumor lysis syndrome, electrolyte disturbances, and venous thromboembolism
  • Discuss strategies for management of oncologic emergencies, including guideline-directed, evidence-based recommendations for minimizing morbidity and mortality risk in patients with oncologic emergencies
  • Identify top-line clinical trial results supporting use of specific interventions in the management of patients with oncologic emergencies
  • Determine the value of nursing interventions in oncologic emergencies, including use of appropriate monitoring strategies, guideline-based treatment, and supportive care approaches, for patients at risk of oncologic emergencies

Faculty, Staff, and Planners’ Disclosures


Beth Faiman
Beth Faiman, PhD, MSN, APRN-BC, AOCN
Adult Nurse Practitioner
Department of Hematology and Medical Oncology
Cleveland Clinic Taussig Cancer Institute
Cleveland, OH

Disclosures: No relevant financial relationships with commercial interests to disclose.

Martha Lassiter
Martha Lassiter, RN, MSN, AOCNS, BMTCN
ABMT and Hematologic Malignancies Clinical Nurse Specialist
Division of Cellular Therapy
Duke University Medical Center
Durham, NC

Disclosures: No relevant financial relationships with commercial interests to disclose.

Laura J. Zitella
Laura J. Zitella, MS, RN, ACNP-BC, AOCN
Nurse Practitioner
Associate Clinical Professor
University of California, San Francisco
San Francisco, CA

Disclosures: Consultant: AbbVie, Amgen, AstraZeneca, Gilead, Merck, Stemline.

The staff of Physicians' Education Resource®, LLC (PER®), have no relevant financial relationships with commercial interests to disclose.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

As a sponsor accredited by the ACCME, it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME/CE activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME/CE activity to disclose all relevant financial relationships with commercial interests. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that creates a COI.

Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This CME/CE activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME/CE activity is for continuing medical and nursing education purposes only and is not meant to substitute for the independent clinical judgment of a physician or nurse relative to diagnostic or treatment options for a specific patient’s medical condition.

The opinions expressed in the content are solely those of the individual faculty members, and do not reflect those of PER® or any of the companies that provided commercial support for this program.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By